open
SAI PARENT

Sai Parenteral’s IPO

Sai Parenteral’s Ltd., founded in 2001, is one of the leading pharmaceutical companies focused on R&D and manufacturing of pharmaceutical products. The firm operates in 2 main business areas: makes and sells its own branded medicines, and also manufactures medicines for other companies internationally. Its product offerings include a wide range of medicines for various health conditions, like cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals, and supplements (VMS), analgesics, and dermatology.

Advertisement (Slot: header)

Price Band

🟡

Lot Size

0 Shares

Issue Size

Approx ₹409 Crores

Current GMP

0 (Apr 2)

IPO Timeline

Open DateApril 2, 2026
Close DateApril 2, 2026
Basis of AllotmentTBA
Listing DateMarch 27, 2026

Subscription Status

Overall subscription

Financial Information

Period EndedRevenueExpensePATAssets
2023₹97.03₹89.78₹4.38₹133.96
2024₹155.18₹142.63₹8.42₹268.10
2025₹163.74₹143.84₹14.43₹272.39
Sep 2025₹89.43₹78.27₹7.76₹376.24

Promoters

ParticularShares% Share
Promoter Holding Pre Issue3,69,08,82361.23%
Promoter Holding Post Issue4,41,79,231-%

Objects of the Issue

  • Arihant Capital Markets Ltd.

Open Demat Account to Apply

Advertisement (Slot: sidebar)